BCTX
Briacell Therapeutics
BCTX
BCTX
18 hedge funds and large institutions have $14.2M invested in Briacell Therapeutics in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
16% less capital invested
Capital invested by funds: $17M → $14.2M (-$2.81M)
33% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 6
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
18
Holding in Top 10
1
Calls
$5.66M
Puts
$199K
Top Buyers
| 1 | +$3.9M | |
| 2 | +$313K | |
| 3 | +$253K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$244K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$115K |
Top Sellers
| 1 | -$7.54M | |
| 2 | -$103K | |
| 3 | -$82K | |
| 4 |
BCM
Bluefin Capital Management
New York
|
-$21.1K |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$19.1K |